Anthony El-Khoueiry
Anthony El-Khoueiry
Associate Professor, University of Southern California Norris Comprehensive Cancer Center
Verified email at
Cited by
Cited by
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
AB El-Khoueiry, B Sangro, T Yau, TS Crocenzi, M Kudo, C Hsu, TY Kim, ...
The Lancet 389 (10088), 2492-2502, 2017
Cabozantinib in patients with advanced and progressing hepatocellular carcinoma
GK Abou-Alfa, T Meyer, AL Cheng, AB El-Khoueiry, L Rimassa, BY Ryoo, ...
New England Journal of Medicine 379 (1), 54-63, 2018
Effect of first-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic colorectal cancer: a …
AP Venook, D Niedzwiecki, HJ Lenz, F Innocenti, B Fruth, JA Meyerhardt, ...
Jama 317 (23), 2392-2401, 2017
Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma
M Javle, M Lowery, RT Shroff, KH Weiss, C Springfeld, MJ Borad, ...
Journal of Clinical Oncology 36 (3), 276, 2018
Adjuvant therapy for resected biliary tract cancer: ASCO clinical practice guideline
RT Shroff, EB Kennedy, M Bachini, T Bekaii-Saab, C Crane, J Edeline, ...
Journal of Clinical Oncology 37 (12), 1015-1027, 2019
SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and …
E Ben-Josef, KA Guthrie, AB El-Khoueiry, CL Corless, MM Zalupski, ...
Journal of Clinical Oncology 33 (24), 2617, 2015
AKT inhibition in solid tumors with AKT1 mutations
DM Hyman, LM Smyth, MTA Donoghue, SN Westin, PL Bedard, EJ Dean, ...
Journal of Clinical Oncology 35 (20), 2251, 2017
Phase I/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040.
AB El-Khoueiry, I Melero, TS Crocenzi, TH Welling, TC Yau, W Yeo, ...
Journal of Clinical Oncology 33 (18_suppl), LBA101-LBA101, 2015
Nivolumab (NIVO)+ ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
T Yau, YK Kang, TY Kim, AB El-Khoueiry, A Santoro, B Sangro, I Melero, ...
Journal of Clinical Oncology 37 (15_suppl), 4012-4012, 2019
First-in-man phase I study of GC33, a novel recombinant humanized antibody against glypican-3, in patients with advanced hepatocellular carcinoma
AX Zhu, PJ Gold, AB El-Khoueiry, TA Abrams, H Morikawa, N Ohishi, ...
Clinical cancer research 19 (4), 920-928, 2013
SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
AB El-Khoueiry, CJ Rankin, E Ben-Josef, HJ Lenz, PJ Gold, RD Hamilton, ...
Investigational new drugs 30, 1646-1651, 2012
Impact of sex on the survival of patients with hepatocellular carcinoma: a surveillance, epidemiology, and end results analysis
D Yang, DL Hanna, J Usher, J LoCoco, P Chaudhari, HJ Lenz, ...
Cancer 120 (23), 3707-3716, 2014
Reversible posterior leukoencephalopathy syndrome induced by RAF kinase inhibitor BAY 43-9006
R Govindarajan, J Adusumilli, DL Baxter, A El-Khoueiry, SI Harik
Journal of Clinical Oncology 24 (28), e48-e48, 2006
Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer …
G Lurje, F Nagashima, W Zhang, D Yang, HM Chang, MA Gordon, ...
Clinical Cancer Research 14 (23), 7884-7895, 2008
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
AB El-Khoueiry, C Rankin, AB Siegel, S Iqbal, IY Gong, KC Micetich, ...
British journal of cancer 110 (4), 882-887, 2014
Rates and predictors of chemotherapy use for stage III colon cancer: a systematic review
DA Etzioni, AB El‐Khoueiry, RW Beart Jr
Cancer 113 (12), 3279-3289, 2008
A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors.
AB El-Khoueiry, Y Ning, D Yang, S Cole, M Kahn, M Zoghbi, J Berg, ...
Journal of Clinical Oncology 31 (15_suppl), 2501-2501, 2013
Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III …
GK Abou-Alfa, T Meyer, AL Cheng, AB El-Khoueiry, L Rimassa, BY Ryoo, ...
Journal of Clinical Oncology 36 (4_suppl), 207-207, 2018
Nivolumab in sorafenib-naive and-experienced patients with advanced hepatocellular carcinoma: CheckMate 040 study
TS Crocenzi, AB El-Khoueiry, T Yau, I Melero, B Sangro, M Kudo, C Hsu, ...
J Clin Oncol 35 (suppl 15), 4013, 2017
Common cancer stem cell gene variants predict colon cancer recurrence
A Gerger, W Zhang, D Yang, P Bohanes, Y Ning, T Winder, MJ LaBonte, ...
Clinical Cancer Research 17 (21), 6934-6943, 2011
The system can't perform the operation now. Try again later.
Articles 1–20